跳至主要内容
临床试验/NCT01553643
NCT01553643Unknown4 期

A Randomized Double Blind Placebo Control Study of Huang-Chi-Wu-Wu- Tang in Patients With Intracranial Arterial Stenosis

China Medical University Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
80
试验地点
1
主要终点
Primary outcome measure was the improvement hemodynamics at intracranial vessels in the M1 segment of middle cerebral artery (MCA) or basilar artery (BA) shown in transcranial color-coded sonography (TCCS).

研究概览

简要总结

Intracranial arterial prominent stenosis (IAPS) is one of main cause of stroke especially in Asia. Although antiplatelet aggregative or anticoagulant agent and even surgical operation are used to treat patients with IAPS, the incidence of stroke occurrence still remains high. In addition, symptomatic IAPS most common cause continuous deterioration, thus, increase the incidence of stroke. Therefore, there is a good method to reduce the inceidence of stroke that is to prevent the progressive deterioration of IAPS.

Huang-Chi-Wu-Wu-Tang is made of Astrgalus membranaceus (Fisch.) Gge , Paeonia lactiflora Pall , Cinnamom Twig , Zingiber officinale Rose , Ziziphus jujube Mill , and can treat hemiplegia in the traditional Chinese medicine writings. Astragaloside IV is a component of Astrgalus membranaceus, may reduce th cerebral infarction area in middle cerebral arterial occlusion mice. The investigators previous studies have known that paeoniflorin that a component of Paeonia lactiflora Pall can decrease the cerebral infarction area and neurological deficit in middle cerebral arterial occlusion rats. Therefore, the purpose of the present study was to investigate the effect of Huang-Chi-Wu-Wu-Tang on patients with IAPS.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
41 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Had received Transcranial Doppolar Sonography.
  • Age >40 years old.
  • Gender: Male or female.
  • The subject or their legal representative gave written informed consent to participate.
  • Meet with one of the two Transcranial Doppolar Sonography results below:
  • The evaluated standard of MCA M1 stenosis of 50-99% are as follows:
  • PSV >140 cm/s
  • MFV >100 cm/s
  • The evaluated standard of BA stenosis of 50-99% are as follows:
  • PSV >100 cm/s
  • MFV >60 cm/s

排除标准

  • Refused to sign the Informed Consent Form.
  • Too irritable to accept the evaluation.
  • Age ≦40 years old.
  • Major diseases such as Myocardial Infarction、Heart failure、Chronic pulmonary obstructive disease(COPD)with dyspnea、Liver failure or Renal failure.
  • Pregnancy or breast-feeding.

研究组 & 干预措施

Chinese Herb Huang-Chi-Wu-Wu-Tang

Experimental

干预措施: Chinese Herb Huang-Chi-Wu-Wu-Tang (Drug)

Placebo

Placebo Comparator

干预措施: placebo (Drug)

结局指标

主要结局

Primary outcome measure was the improvement hemodynamics at intracranial vessels in the M1 segment of middle cerebral artery (MCA) or basilar artery (BA) shown in transcranial color-coded sonography (TCCS).

时间窗: 3 years(all patients)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验